Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer.
about
Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?Taxanes in the elderly patient with metastatic breast cancerMajor clinical research advances in gynecologic cancer in 2010Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional agePharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose.Clinical pharmacology of cancer therapies in older adults.Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.Pharmacokinetics of chemotherapy in the older patient.Tolerance to chemotherapy in elderly patients with cancer.Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.Effect of age on drug metabolism in women with breast cancer.Therapeutic management of breast cancer in the elderly.Injectable in situ forming controlled release implant composed of a poly-ether-ester-carbonate and applications in the field of chemotherapy.The impact of medication therapy management in older oncology patients.Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.
P2860
Q26745420-B49E2F99-38BB-41AD-80D8-0E9FD9BDD5D6Q26785458-21F795E5-124C-43BC-9554-D96D0CABE509Q34517694-D08F25CF-891C-49A8-8592-60B1FEABDB3AQ34959972-02C9E3A8-D047-43B6-8B86-0A9E0704EB56Q35674153-BA1BF6F5-CEE0-4FAD-9535-E5C61DC68302Q36459787-F3395913-65FB-4647-9F6F-3F2C830636BEQ36506987-6FAFEE72-0AB8-4250-A415-74E58EF3CE46Q36715263-D1BACD73-5E07-460F-AA9C-2B60669DBC41Q36715266-32822E0B-B716-49C7-9AF3-D0D5CDC9739DQ36924356-E9C7A060-8B0A-4727-9E5F-D9F355721EC9Q36988077-DF60C4B2-8294-4A01-B0B1-86415A9080B1Q37325560-AED10C35-6285-4014-A26D-3A6140C05A0CQ37842506-BA8DCE87-EC89-4583-820B-A7AB60290C1AQ39359989-8EAE8D28-F445-4066-AC46-5B3B64D9DBB1Q45077543-0324B341-F6E1-46D3-976E-1A18AC564804Q46753331-C73F8559-0E36-4E34-BC31-631336E93279
P2860
Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Altered clearance of unbound p ...... with metastatic breast cancer.
@ast
Altered clearance of unbound p ...... with metastatic breast cancer.
@en
type
label
Altered clearance of unbound p ...... with metastatic breast cancer.
@ast
Altered clearance of unbound p ...... with metastatic breast cancer.
@en
prefLabel
Altered clearance of unbound p ...... with metastatic breast cancer.
@ast
Altered clearance of unbound p ...... with metastatic breast cancer.
@en
P2093
P1476
Altered clearance of unbound p ...... with metastatic breast cancer.
@en
P2093
Bontenbal M
Smorenburg CH
Sparreboom A
ten Tije AJ
van Zomeren DM
P304
P356
10.1016/S0959-8049(02)00611-1
P577
2003-01-01T00:00:00Z